WORK Medical Tech Holds Shareholder Meeting

TL;DR

WORK Medical Tech had its shareholder meeting Sept 12, results are in.

AI Summary

WORK Medical Technology Group LTD held an Extraordinary General Meeting of Shareholders on September 12, 2025. The company is a foreign private issuer filing a Form 6-K report. The meeting's results are detailed in this filing, which is for the month of September 2025.

Why It Matters

This filing indicates a significant corporate event for WORK Medical Technology Group LTD, potentially impacting its governance and future strategic decisions.

Risk Assessment

Risk Level: low — The filing is a routine report of a shareholder meeting and does not contain information that suggests immediate financial or operational risk.

Key Players & Entities

• WORK Medical Technology Group LTD (company) — Filer of the report
• September 12, 2025 (date) — Date of the Extraordinary General Meeting of Shareholders

FAQ

Filing Documents

• ea0257173-6k_work.htm (6-K) — 17KB
• 0001213900-25-087216.txt ( ) — 18KB

From the Filing

OF FOREIGN PRIVATE ISSUER UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2025 Commission File Number: 001-42256 WORK Medical Technology Group LTD Floor 23, No. 2 Tonghuinan Road Xiaoshan District, Hangzhou City, Zhejiang Province The People’s Republic of China (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F Form 40-F Results of WORK Medical Technology Group LTD’s Extraordinary General Meeting of Shareholders The Extraordinary General Meeting of Shareholders (the “Meeting”) of WORK Medical Technology Group LTD (the “Company”) was held at Floor 23, No. 2 Tonghuinan Road, Xiaoshan District, Hangzhou City, Zhejiang Province, China, on September 12, 2025, at 9:30 a.m. EST, with the ability given to the shareholders to join virtually via live audio webcast at http://www.virtualshareholdermeeting.com/WOK2025SM. At the close of business on August 20, 2025, the record date for the determination of shareholders entitled to vote at the Meeting, there were 53,699,442 Class A ordinary shares outstanding, each share being entitled to one vote, and 7,592,500 Class B ordinary shares (together with the Class A ordinary shares, the “Ordinary Shares”), each share being entitled to 20 votes, constituting all of the outstanding voting securities of the Company. At the Meeting, the holders of 28,106,006 Ordinary Shares of the Company, representing 160,488,506 votes, were represented in person or by proxy, constituting a quorum. At the Meeting, the shareholders of the Company adopted the following resolutions : 1. An ordinary resolution to approve one or more share consolidations, 2. An ordinary resolution to approve a share capital increase, 3. A special resolution to approve the Company’s adoption of a further amended and restated memorandum of association, conditional upon the approval of the proposed share capital increase, to reflect the relevant share consolidation and the relevant share capital increase upon their effectiveness; and 4. An ordinary resolution to approve any adjournment of the Meeting, if necessary. The results of the vote at the Meeting for the resolutions were as follows: * For Against Abstain No. 1 141,283,402 91,722 23,258 No. 2 141,281,969 91,154 25,259 No. 3 159,772,692 538,712 177,102 No. 4 159,773,176 538,068 177,262 * The numbers in this column correspond to the resolutions enumerated in the third paragraph of this report. 1 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Dated: September 12, 2025 WORK Medical Technology Group LTD By: /s/ Shuang Wu Name: Shuang Wu Title: Chief Executive Officer and Chairman of the Board of Directors 2

View Full Filing

View this 6-K filing on SEC EDGAR